Skip to main navigation
Menu
Menu
Home
About Trevena
About Trevena
Management
Board of Directors
Careers
Pipeline
Our Pipeline
Oliceridine injection
Moderate-to-Severe Acute Pain
Oliceridine Development
TRV250
TRV734
Platform
What is a Biased Ligand?
History of Biased Ligands
Investors
Investor Relations
Press Releases
Investor Presentations
Analyst Coverage
Corporate Governance
Management
Board of Directors
Committee Composition
Contact the Board
Financials & Filings
SEC Filings
Annual Reports and Proxies
Quarterly Results
Stock Information
Historic Stock Lookup
Investment Calculator
Investor FAQs
Publications
All Publications
Contact
Contact
Directions to Trevena
Investor Relations
Investor Relations
Press Releases
Investor Presentations
Analyst Coverage
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Corporate Presentation
Shareholder Tools
Printed Materials
Email Alerts
Download Library
Print
Share
X
Facebook
Google+
LinkedIn
Twitter
RSS
Investor Presentations
21st Annual BIO CEO & Investor Conference
Feb 12, 2019 9:15 AM EST
Listen to webcast
Remind Me